New Zealand markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.26+0.84 (+0.98%)
At close: 01:00PM EST
85.81 -0.45 (-0.52%)
After hours: 04:29PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 107.14B
Enterprise value 126.70B
Trailing P/E 32.36
Forward P/E 12.97
PEG ratio (5-yr expected) 0.70
Price/sales (ttm)3.97
Price/book (mrq)5.08
Enterprise value/revenue 4.67
Enterprise value/EBITDA 23.08

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 322.09%
S&P500 52-week change 3-13.51%
52-week high 386.41
52-week low 357.17
50-day moving average 372.11
200-day moving average 364.42

Share statistics

Avg vol (3-month) 38.24M
Avg vol (10-day) 36.79M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.09%
% held by institutions 182.78%
Shares short (30 Oct 2022) 419.07M
Short ratio (30 Oct 2022) 42.23
Short % of float (30 Oct 2022) 41.52%
Short % of shares outstanding (30 Oct 2022) 41.52%
Shares short (prior month 29 Sept 2022) 416.45M

Dividends & splits

Forward annual dividend rate 42.92
Forward annual dividend yield 43.43%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 33.39%
5-year average dividend yield 43.78
Payout ratio 4109.85%
Dividend date 328 Dec 2022
Ex-dividend date 413 Dec 2022
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 12.29%
Operating margin (ttm)39.30%

Management effectiveness

Return on assets (ttm)10.28%
Return on equity (ttm)15.56%

Income statement

Revenue (ttm)27.14B
Revenue per share (ttm)21.62
Quarterly revenue growth (yoy)-5.10%
Gross profit (ttm)21.78B
EBITDA 12.78B
Net income avi to common (ttm)3.33B
Diluted EPS (ttm)2.64
Quarterly earnings growth (yoy)-31.00%

Balance sheet

Total cash (mrq)6.24B
Total cash per share (mrq)4.97
Total debt (mrq)25.22B
Total debt/equity (mrq)119.78
Current ratio (mrq)1.30
Book value per share (mrq)16.81

Cash flow statement

Operating cash flow (ttm)9.71B
Levered free cash flow (ttm)8.59B